Denali Plans to Submit BLA for Tividenofusp Alfa in Hunter
Syndrome Following Positive Phase 1/2 Data
Phase 1/2 long-term data showed tividenofusp alfa significantly reduced central and peripheral biomarkers to near-normal…














